Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
•Reno CyberKnife focuses on education during Brain Tumor Awareness Month
Tue, 15 May 2012 12:20:09 -0700
•Brain Tumor Patient Community Delivers Priorities to Congress: Invest in Research and Ensure Access to Oral Chemotherapy
Mon, 07 May 2012 05:02:47 -0700
•Research and Markets: Metastatic Brain Tumor - Pipeline Review, H1 2012
Tue, 08 May 2012 09:01:00 -0700
•American Brain Tumor Association Offers “Top Ten” Brain Tumor Facts
Thu, 03 May 2012 09:51:23 -0700
•Lions RB Jerome Harrison will not play in 2012 while recovering from surgery to remove brain tumor
Tue, 15 May 2012 14:35:56 -0700
•Stem cells boost brain tumor treatments for some patients, study finds
Thu, 10 May 2012 08:39:11 -0700
•Young York County boy dies of brain tumor; received 1000's of cards
Mon, 14 May 2012 16:37:09 -0700
•Visioneer “Where There Is a Need” Program Supports the National Brain Tumor Society
Tue, 17 Apr 2012 07:30:00 -0700
•Houston hospital live tweets brain tumor surgery
Wed, 09 May 2012 06:00:14 -0700
•Brain tumor survivor, family run for charity
Tue, 01 May 2012 12:02:24 -0700

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology. ProbeSetAnalyzer.com, a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

  
 

Join family, friends and Brain Tumor patients at the 6th Annual Tom Atkinson Memorial 5K Walk/Run. The walk begins Saturday, May 12, 2012 9:00 am at Lakewood High School. All proceeds from this event to benefit the UCLA Neuro-Oncology Program.

• Directions to: Lakewood High School
• UCLA Neuro-Oncology: Online Giving

Dani Saleh Brain Cancer Research Fund at UCLA


The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring / Summer 2012
Breakthroughs



It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.


Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.


Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.


Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.


Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2012 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2012 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:5/16/2012 9:40:01 AM PST]